Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjögren's syndrome

Lupus

Volumn 20, Issue 9, 2011, Pages 928-935

  Bartoloni, E ^a   Ludovini, V ^b   Alunno, A ^a   Pistola, L ^b   Bistoni, O ^a   Crino L ^b   Gerli, R ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Perugia General Hospital   (Italy)

Author keywords

disease activity; Sj gren's syndrome; systemic lupus erythematosus

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; DISEASE SEVERITY; DNA EXTRACTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; DISEASE PROGRESSION; DNA; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 80052553085     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311399606     Document Type: Article

References (41)

1. Mandel P, Metais P. Les acides nucleiques du plasma sanguine chez l'homme. CR Acad Sci Paris. 1947 ; 142: 241-3
2. Yoon KA, Park S, Lee SH, Kim JH, Lee JS. Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls. J Mol Diagn. 2009 ; 11: 182-5
3. Ludovini V, Pistola L, Gregorc V, et al. Plasma DNA, micro satellite alterations, and p53 tumor mutation are associated with disease-free survival in radically resected non-small cell lung cancer patients. J Thorac Oncol. 2008 ; 3: 365-373 (Pubitemid 351489476)
4. Zhang R, Shao F, Wu X, Ying K. Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: a meta-analysis. Lung Cancer. 2010 ; 69: 225-231
5. Tsang JC, Lo YM. Circulating nucleic acids in plasma/serum. Pathology. 2007 ; 39: 197-207 (Pubitemid 46439650)
6. Uzuelli JA, Dias-Junior CA, Izidoro-Toledo TC, Gerlach RF, Tanus-Santos JE. Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism. Clin Chim Acta. 2009 ; 409: 112-116
7. Suzuki N, Kamataki A, Yamaki J, Homma Y. Characterization of circulating DNA in healthy human plasma. Clin Chim Acta. 2008 ; 387: 55-58 (Pubitemid 350050929)
8. Tan EM, Schur PH, Carr RI, Unkel HG. Deoxyribonucleic acid [DNA] and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest. 1966 ; 45: 1732-1740
9. Raptis L, Menard HA. Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest. 1980 ; 66: 1391-1399 (Pubitemid 11205601)
10. Klemp P, Meyers OL, Harley EH. Measurement of plasma DNA by a physicochemical method: relevance in SLE. Ann Rheum Dis. 1981 ; 40: 593-599 (Pubitemid 12223271)
11. Leon SA, Ehrlich GE, Shapiro B, Labbate VA. Free DNA in the serum of rheumatoid arthritis patients. J Rheumatol. 1977 ; 4: 139-142
12. McCoubrey-Hoyer A, Okarma TB, Holman HR. Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus. Am J Med. 1984 ; 77: 23-34 (Pubitemid 14084902)
13. Chen J, Meister S, Urbonaviciute V, et al. Sensitive detection of plasma/serum DNA in patients with systemic lupus erythematosus. Autoimmunity. 2007 ; 40: 307-310 (Pubitemid 46845527)
14. Mosca M, Giuliano T, Cuomo G, et al. Cell-free DNA in the plasma of patients with systemic sclerosis. Clin Rheumatol. 2009 ; 28: 1437-1440
15. Pisetsky DS. DNA as a marker of cell death in systemic lupus erythematosus. Rheum Dis Clin N Am. 2004 ; 30: 575-587 (Pubitemid 38917002)
16. van der Vaart M, Pretorius PJ. Circulating DNA. Its origin and fluctuation. Ann N Y Acad Sci. 2008 ; 1137: 18-26
17. Pisetsky DS, Lipsky PE. Microparticles as autoadjuvants in the pathogenesis of SLE. Nat Rev Rheumatol. 2010 ; 6: 368-372
18. Steinman CR. Circulating DNA in systemic lupus erythematosus. Association with central nervous system involvement and systemic vasculitis. Am J Med. 1979 ; 67: 429-435 (Pubitemid 10237026)
19. Vitali C, Bombardieri S, Jonsson R, et al., for European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 ; 61: 554-558 (Pubitemid 34539104)
20. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria fort he classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277 (Pubitemid 13221242)
21. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 ; 31: 315-324 (Pubitemid 18091653)
22. Vitali C, Palombi G, Baldini C, et al. Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum. 2007 ; 56: 2223-2231 (Pubitemid 47173570)
23. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH,. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 1992 ; 35: 630-640
24. Stoll T, Seifert B, Isenberg DA. SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol. 1996 ; 35: 248-254
25. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002 ; 29: 288-291 (Pubitemid 34118775)
26. Heid CA, Stevens J, Livak K, Williams PM. Real time quantitative PCR. Genome Res. 1996 ; 6: 986-994 (Pubitemid 26388091)
27. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus acquaticus DNA polymerase. Proc Natl Acad Sci USA. 1991 ; 88: 7276-7280 (Pubitemid 21915133)
28. Steinman CR. Circulating DNA in systemic lupus erythematosus. Isolation and characterization. J Clin Invest. 1984 ; 73: 832-841 (Pubitemid 14156867)
29. Lee TH, Montalvo L, Chrebtow V, Busch MP. Quantitation of genomic DANN in plasma and serum samples: higher concentration of genomic DANN found in serum than in plasma. Transfusion. 2001 ; 41: 276-282 (Pubitemid 32220522)
30. Zeerleder S. The struggle to detect circulating DNA. Crit Care. 2006 ; 10: 142-144
31. Rumore P, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus. J Clin Invest. 1990 ; 86: 69-74
32. Chen JS, Fineschi S, Morozzi G, Marcolongo R, Chen MG, Galeazzi M. Modifications of DANN patterns in plasma and nucleated blood cells from systemic sclerosis patients. Clin Exp Rheumatol. 2001 ; 19: 492-494 (Pubitemid 32894597)
33. Galeazzi M, Morozzi G, Piccini M, et al. Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders. Autoimmunity Rev. 2003 ; 2: 50-55 (Pubitemid 37443872)
34. Pisetsky DS, Jiang N. The generation of extracellular DNA in SLE: the role of death and sex. Scand J Immunol. 2006 ; 64: 200-204 (Pubitemid 44215108)
35. Pisetsky D. The immune response to cell death in SLE. Autoimmunity Rev. 2004 ; 3: 500-504 (Pubitemid 39531241)
36. Jimenez F, Aiba-Masago S, Al Hashimi I, et al. Activated caspase 3 and cleaved poly [ADP-ribose] polymerase in salivary epithelium suggest a pathogenetic mechanism for Sjögren's syndrome. Rheumatology. 2002 ; 41: 338-342 (Pubitemid 34537872)
37. Sisto M, Lisi S, Lofrumento D, D'Amore M, Scagliusi P, Mitolo V. Autoantibodies from Sjögren's syndrome trigger apoptosis in salivary gland cell line. Ann N Y Acad Sci. 2007 ; 1108: 418-425 (Pubitemid 47528755)
38. Hughes GR, Cohen SA, Lightfoot RW, Meltzer JI, Christian CL. The release of DNA into serum and synovial fluid. Arthritis Rheum. 1971 ; 14: 259-266
39. Bryzgunova O, Skvortsova TE, Kolesnikova EV, et al. Isolation and comparative study of cell-free nucleic acids from human urine. Ann N Y Acad Sci. 2006 ; 1075: 334-340 (Pubitemid 44532802)
40. Korabecna M, Opatrna S, Wirth J, et al. Cell-free plasma DANN during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease. Ann N Y Acad Sci. 2008 ; 1137: 296-301
41. Porciello G, Scarpato R, Ferri C, et al. Spontaneous chromosome damage [micronuclei] in systemic sclerosis and Raynaud's phenomenon. J Rheumatol. 2003 ; 30: 1244-1247 (Pubitemid 36666348)